News

Monthly weight-loss shots on the horizon! Learn about new drugs like MariTide and why Black participation in clinical trials ...
In the same way weight varies from person to person, so do the best weight loss strategies. While some people succeed with diet and exercise alone, others find that adding weight loss medications like ...
MariTide, a groundbreaking weight loss medication, shows 16% weight reduction in trials. Learn about this promising monthly ...
MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...
At the diabetes conference, Eli Lilly presented results of a phase 1 trial of its experimental drug, eloralintide. Unlike GLP-1 drugs, it targets a hormone that slows stomach emptying. Over 12 weeks, ...
These powerful weight loss and Type 2 diabetes medications are all GLP-1 drugs. MariTide is, too, but differs in that it also contains a monoclonal antibody, which helps the drug stay in the body ...
MariTide led to around 20% weight loss in obesity without diabetes vs. 2.6% with placebo. Amgen begins a 72-week Phase 3 MariTide trial, targeting obesity and comorbidities, including heart ...
The researchers working on MariTide are currently preparing for a 72-week phase 3 trial, and evaluating if the drug can help people lose more weight than the ~16% they shed in the phase II trial.
Amgen's weight-loss drug MariTide had a successful Phase 2 trial so the company is expanding development plans to study its use for heart disease and sleep apnea.
Amgen's long-acting experimental obesity drug MariTide needs to be given at a low starting dose to limit side effects like ...
"MariTide delivered strong efficacy, including sustained weight loss without a plateau in the 52-week Phase 2 study and meaningful improvements in cardiometabolic risk factors, representing a ...